ASRS
RIGL icon

Arizona State Retirement System’s Rigel Pharmaceuticals RIGL Stock Holding History

Arizona State Retirement System’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,676
Closed -$55K – 2249
2022
Q3 		$55K Buy
4,676
+42
+0.9% +$568 ﹤0.01% 2156
2022
Q2 		$52K Buy
4,634
+11
+0.2% +$221 ﹤0.01% 2194
2022
Q1 		$138K Buy
4,623
+25
+0.5% +$677 ﹤0.01% 2097
2021
Q4 		$122K Sell
4,598
-37
-0.8% -$1.12K ﹤0.01% 2191
2021
Q3 		$168K Buy
4,635
+42
+0.9% +$1.65K ﹤0.01% 2112
2021
Q2 		$199K Sell
4,593
-326
-7% -$12.3K ﹤0.01% 2122
2021
Q1 		$168K Buy
4,919
+25
+0.5% +$990 ﹤0.01% 2072
2020
Q4 		$171K Sell
4,894
-192
-4% -$5.56K ﹤0.01% 1995
2020
Q3 		$122K Buy
5,086
+1,281
+34% +$31.5K ﹤0.01% 1909
2020
Q2 		$70K Sell
3,805
-130
-3% -$2.34K ﹤0.01% 1832
2020
Q1 		$61K Buy
+3,935
New +$83.8K ﹤0.01% 1733

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arizona State Retirement System's RIGL Position: Q4 2022 in Review

Arizona State Retirement System sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 4,676 shares — an estimated $55K sold.

Arizona State Retirement System first reported a position in RIGL in Q1 2020 and held it in 11 quarters. The position peaked at $199K in Q2 2021. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

  • Arizona State Retirement System reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Arizona State Retirement System sold 4,676 Rigel Pharmaceuticals shares in Q4 2022, an estimated $55K.
  • Arizona State Retirement System first reported a position in Rigel Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • Arizona State Retirement System's Rigel Pharmaceuticals position peaked at $199K in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Arizona State Retirement System's 13F filing for Q4 2022, filed 8 Feb 2023.